Aldridge SJ, Akbari A, Edwards A, Lifford K, Abbel D, Cannegieter S, et al. The (dis)continuing of antithrombotic drugs and its implications for occurrence of adverse cardiovascular and bleeding events in cancer patients during end of life. IJPDS [Internet]. 2024 Sept. 10 [cited 2026 Oct. 24];9(5). Available from: https://ijpds.org/index.php/ijpds/article/view/2826